biotech

Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on November 6, 2006

Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds
e-Therapeutics, a spin off biotech company from Newcastle University has partnered with Brazilian company Grupo TCI to establish a joint research facility close to the Amazonian and Atlantic rain forests. The collaboration aims to screen for lead compounds from the plants found in these rain forests. e-Therapeutics is also collaborating with CURA, a pharmaceutical consortium backed by the Brazilian Government.
Professor Young, who is now Pro-Vice-Chancellor at Newcastle University, said: 'This is a fantastic opportunity to investigate Brazil's colossal biodiversity with our cutting edge technology. There is enormous potential for drug discovery in the rain forests, where there are millions of plant species, many of which produce bioactive chemicals.'

More details from Newcastle University's press release.


Permalink: Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds

Tags: drug+discovery  medicines  rain+forest  biodiversity    biotech  lead+compounds  american+forests 

Vote for Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds:

  • Currently 8.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.67 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells